Pfizer, in partnership with Bristol Myers Squibb, has launched a direct-to-patient sales strategy for Eliquis®, aiming to ...

Analysts expect strong Netflix quarterly earnings, even as growth from its password-sharing clampdown slows. Here's what Wall ...

Many Wall Street analysts keep boosting their stock price target as the streaming giant's shares have gained around 40 ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Pfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Irvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases in the United States and internationally. With a market cap ...

On a per-share basis, the New York-based company said it had profit of 52 cents. Earnings, adjusted for amortization costs and restructuring costs, were 92 cents per share.

Pfizer (NYSE:PFE – Get Free Report) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Tuesday, April 29th. Analysts expect Pfizer to post earnings of $0.67 ...

Pfizer PFE will report its first-quarter earnings on April 29, before market open. The Zacks Consensus Estimate for sales and earnings for the first quarter is pegged at $13.88 billion and 67 ...

Pfizer Inc (NYSE:PFE) is scheduled to release its first quarter 2025 earnings on 29 April.

Pfizer’s PFE 2024 revenue reached $63.6 billion, near the high end of its $61 billion-$64 billion guidance range. Management reaffirmed expectations for 2025 revenue of $61 billion-$64 billion ...